California’s Governor Wants State to Make Its Own Insulin

California Gov. Gavin Newsom is proposing to spend $100 million to distribute and manufacture insulin in the state to reduce costs for patients.

If included in the state’s fiscal 2022-2023 budget, the funding for the CalRx Biosimilar Insulin Initiative would make California the first state to use the strategy as Congress continues to look for ways to lower out-of-pocket costs for diabetic patients.

The requested $100 million would support the production of three low-cost biosimilar insulin products at a manufacturing facility funded by the state.